-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
-
(2005)
Ca-A Cancer Journal for Clinicians
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
3
-
-
27744507676
-
Increasing incidence of colorectal cancer in Asia: Implications for screening
-
DOI 10.1016/S1470-2045(05)70422-8, PII S1470204505704228
-
Sung JJ, Lau JY, Goh KL, Leung WK,. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6: 871-6. (Pubitemid 41614799)
-
(2005)
Lancet Oncology
, vol.6
, Issue.11
, pp. 871-876
-
-
Sung, J.J.Y.1
Lau, J.Y.W.2
Goh, K.L.3
Leung, W.K.4
Chen, M.H.5
Li, C.J.6
Tandon, R.7
Makharia, G.8
Abdullah, M.9
Fujita, R.10
Hilmi, I.11
Kim, J.Y.12
Kim, H.J.13
Yang, S.-K.14
Kim, W.H.15
Kim II, T.16
Byeon, J.-S.17
Hilmi, I.18
Sollano, J.19
Ong, E.20
Tan, J.21
Ho, L.22
Yeoh, K.G.23
Wang, C.-Y.24
Wu, D.-C.25
Kongkam, P.26
Kullavanijaya, P.27
more..
-
4
-
-
2542528446
-
Clinical practice. Surveillance strategies after curative treatment of colorectal cancer
-
Pfister DG, Benson AB 3rd, Somerfield MR,. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med 2004; 350: 2375-82.
-
(2004)
N Engl J Med
, vol.350
, pp. 2375-2382
-
-
Pfister, D.G.1
Benson III, A.B.2
Somerfield, M.R.3
-
5
-
-
13744260035
-
Colorectal cancer prevention
-
DOI 10.1200/JCO.2005.08.097
-
Hawk ET, Levin B,. Colorectal cancer prevention. J Clin Oncol 2005; 23: 378-91. (Pubitemid 46206885)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.2
, pp. 378-391
-
-
Hawk, E.T.1
Levin, B.2
-
6
-
-
11144356831
-
Methylation changes in faecal DNA: A marker for colorectal cancer screening?
-
DOI 10.1016/S0140-6736(04)16002-9, PII S0140673604160029
-
Muller HM, Oberwalder M, Fiegl H, et al., Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 2004; 363: 1283-5. (Pubitemid 38496491)
-
(2004)
Lancet
, vol.363
, Issue.9417
, pp. 1283-1285
-
-
Muller, H.M.1
Oberwalder, M.2
Fiegl, H.3
Morandell, M.4
Goebel, G.5
Zitt, M.6
Muhlthaler, M.7
Ofner, D.8
Margreiter, R.9
Widschwendter, M.10
-
7
-
-
53049087109
-
Genomic and epigenetic instability in colorectal cancer pathogenesis
-
Grady WM, Carethers JM,. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008; 135: 1079-99.
-
(2008)
Gastroenterology
, vol.135
, pp. 1079-1099
-
-
Grady, W.M.1
Carethers, J.M.2
-
8
-
-
72449176846
-
Molecular origins of cancer: Molecular basis of colorectal cancer
-
Markowitz SD, Bertagnolli MM,. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-60.
-
(2009)
N Engl J Med
, vol.361
, pp. 2449-2460
-
-
Markowitz, S.D.1
Bertagnolli, M.M.2
-
9
-
-
0037417585
-
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
-
Bossuyt PM, Reitsma JB, Bruns DE, et al., Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003; 326: 41-4. (Pubitemid 36110721)
-
(2003)
British Medical Journal
, vol.326
, Issue.7379
, pp. 41-44
-
-
Bossuyt, P.M.1
Reitsma, J.B.2
Bruns, D.E.3
Gatsonis, C.A.4
Glasziou, P.P.5
Irwig, L.M.6
Lijmer, J.G.7
Moher, D.8
Rennie, D.9
De Vet, H.C.W.10
-
10
-
-
2942700307
-
The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews
-
Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J,. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3: 25.
-
(2003)
BMC Med Res Methodol.
, vol.3
, pp. 25
-
-
Whiting, P.1
Rutjes, A.W.2
Reitsma, J.B.3
Bossuyt, P.M.4
Kleijnen, J.5
-
11
-
-
3342974413
-
Conducting systematic reviews of diagnostic studies: Didactic guidelines
-
Deville WL, Buntinx F, Bouter LM, et al., Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002; 2: 9.
-
(2002)
BMC Med Res Methodol.
, vol.2
, pp. 9
-
-
Deville, W.L.1
Buntinx, F.2
Bouter, L.M.3
-
12
-
-
0022992740
-
Meta-analysis in clinical trials
-
DOI 10.1016/0197-2456(86)90046-2
-
DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
-
(1986)
Controlled Clinical Trials
, vol.7
, Issue.3
, pp. 177-188
-
-
DerSimonian, R.1
Laird, N.2
-
13
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
-
(1997)
British Medical Journal
, vol.315
, Issue.7109
, pp. 629-634
-
-
Egger, M.1
Smith, G.D.2
Schneider, M.3
Minder, C.4
-
14
-
-
70349251628
-
Analysis of fecal DNA methylation to detect gastrointestinal neoplasia
-
Nagasaka T, Tanaka N, Cullings HM, et al., Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009; 101: 1244-58.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 1244-1258
-
-
Nagasaka, T.1
Tanaka, N.2
Cullings, H.M.3
-
15
-
-
70249147655
-
Sensitive digital quantification of DNA methylation in clinical samples
-
Li M, Chen WD, Papadopoulos N, et al., Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009; 27: 858-63.
-
(2009)
Nat Biotechnol
, vol.27
, pp. 858-863
-
-
Li, M.1
Chen, W.D.2
Papadopoulos, N.3
-
16
-
-
68449085638
-
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer
-
Kim MS, Louwagie J, Carvalho B, et al., Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS ONE 2009; 4: e6555.
-
(2009)
PLoS ONE
, vol.4
-
-
Kim, M.S.1
Louwagie, J.2
Carvalho, B.3
-
17
-
-
66349102768
-
Methylation of TFPI2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer
-
Glockner SC, Dhir M, Yi JM, et al., Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009; 69: 4691-9.
-
(2009)
Cancer Res
, vol.69
, pp. 4691-4699
-
-
Glockner, S.C.1
Dhir, M.2
Yi, J.M.3
-
18
-
-
35348831351
-
DNA stool test for colorectal cancer: Hypermethylation of the secreted frizzled-related protein-1 gene
-
DOI 10.1007/s10350-007-0286-6
-
Zhang W, Bauer M, Croner RS, et al., DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum 2007; 50: 1618-26; discussion 26-7. (Pubitemid 47583343)
-
(2007)
Diseases of the Colon and Rectum
, vol.50
, Issue.10
, pp. 1618-1626
-
-
Zhang, W.1
Bauer, M.2
Croner, R.S.3
Pelz, J.O.W.4
Lodygin, D.5
Hermeking, H.6
Sturzl, M.7
Hohenberger, W.8
Matzel, K.E.9
-
19
-
-
34247882544
-
Detection of hypermethylated DNA or cyclooxygenase-2 messenger rna in fecal samples of patients with colorectal cancer or polyps
-
DOI 10.1111/j.1572-0241.2007.01108.x
-
Leung WK, To KF, Man EP, et al., Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps. Am J Gastroenterol 2007; 102: 1070-6. (Pubitemid 46698227)
-
(2007)
American Journal of Gastroenterology
, vol.102
, Issue.5
, pp. 1070-1076
-
-
Leung, W.K.1
To, K.-F.2
Man, E.P.S.3
Chan, M.W.Y.4
Hui, A.J.5
Ng, S.S.M.6
Lau, J.Y.W.7
Sung, J.J.Y.8
-
20
-
-
33947498117
-
Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions
-
Huang ZH, Li LH, Yang F, Wang JF,. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol 2007; 13: 950-4. (Pubitemid 46470311)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.6
, pp. 950-954
-
-
Huang, Z.-H.1
Li, L.-H.2
Yang, F.3
Wang, J.-F.4
-
21
-
-
13544257481
-
Analysis of promoter methylation in stool: A novel method for the detection of colorectal cancer
-
DOI 10.1016/S1542-3565(04)00624-X, PII 101053154235650400624X
-
Lenhard K, Bommer GT, Asutay S, et al., Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol. 2005; 3: 142-9. (Pubitemid 40220309)
-
(2005)
Clinical Gastroenterology and Hepatology
, vol.3
, Issue.2
, pp. 142-149
-
-
Lenhard, K.1
Bommer, G.T.2
Asutay, S.3
Schauer, R.4
Brabletz, T.5
Goke, B.6
Lamerz, R.7
Kolligs, F.T.8
-
22
-
-
68149181469
-
Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients
-
discussion 9-63.
-
Baek YH, Chang E, Kim YJ, Kim BK, Sohn JH, Park DI,. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients. Dis Colon Rectum 2009; 52: 1452-9. discussion 9-63.
-
(2009)
Dis Colon Rectum
, vol.52
, pp. 1452-1459
-
-
Baek, Y.H.1
Chang, E.2
Kim, Y.J.3
Kim, B.K.4
Sohn, J.H.5
Park, D.I.6
-
23
-
-
55349115380
-
A simplified, noninvasive stool DNA test for colorectal cancer detection
-
Itzkowitz S, Brand R, Jandorf L, et al., A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 2008; 103: 2862-70.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2862-2870
-
-
Itzkowitz, S.1
Brand, R.2
Jandorf, L.3
-
24
-
-
67649635452
-
N-Myc downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer
-
Melotte V, Lentjes MH, van den Bosch SM, et al., N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 2009; 101: 916-27.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 916-927
-
-
Melotte, V.1
Lentjes, M.H.2
Van Den Bosch, S.M.3
-
25
-
-
67449128445
-
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
-
Hellebrekers DM, Lentjes MH, van den Bosch SM, et al., GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 2009; 15: 3990-7.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3990-3997
-
-
Hellebrekers, D.M.1
Lentjes, M.H.2
Van Den Bosch, S.M.3
-
26
-
-
67349175004
-
Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease
-
Mayor R, Casadome L, Azuara D, et al., Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br J Cancer 2009; 100: 1534-9.
-
(2009)
Br J Cancer
, vol.100
, pp. 1534-1539
-
-
Mayor, R.1
Casadome, L.2
Azuara, D.3
-
27
-
-
34247598254
-
Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran
-
Abbaszadegan MR, Tavasoli A, Velayati A, et al., Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran. World J Gastroenterol 2007; 13: 1528-33. (Pubitemid 46672660)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.10
, pp. 1528-1533
-
-
Abbaszadegan, M.R.1
Tavasoli, A.2
Velayati, A.3
Sima, H.R.4
Vosooghinia, H.5
Farzadnia, M.6
Asadzedeh, H.7
Gholamin, M.8
Dadkhah, E.9
Aarabi, A.10
-
28
-
-
33846214402
-
Improved Fecal DNA Test for Colorectal Cancer Screening
-
DOI 10.1016/j.cgh.2006.10.006, PII S1542356506010445
-
Itzkowitz SH, Jandorf L, Brand R, et al., Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol. 2007; 5: 111-7. (Pubitemid 46096834)
-
(2007)
Clinical Gastroenterology and Hepatology
, vol.5
, Issue.1
, pp. 111-117
-
-
Itzkowitz, S.H.1
Jandorf, L.2
Brand, R.3
Rabeneck, L.4
Schroy III, P.C.5
Sontag, S.6
Johnson, D.7
Skoletsky, J.8
Durkee, K.9
Markowitz, S.10
Shuber, A.11
-
29
-
-
23244439221
-
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene
-
DOI 10.1093/jnci/dji204
-
Chen WD, Han ZJ, Skoletsky J, et al., Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005; 97: 1124-32. (Pubitemid 41511211)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.15
, pp. 1124-1132
-
-
Chen, W.-D.1
Han, Z.J.2
Skoletsky, J.3
Olson, J.4
Sah, J.5
Myeroff, L.6
Platzer, P.7
Lu, S.8
Dawson, D.9
Willis, J.10
Pretlow, T.P.11
Lutterbaugh, J.12
Kasturi, L.13
Willson, J.K.V.14
Rao, J.S.15
Shuber, A.16
Markowitz, S.D.17
-
30
-
-
68149159716
-
Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA
-
Ausch C, Kim YH, Tsuchiya KD, et al., Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Clin Chem 2009; 55: 1559-63.
-
(2009)
Clin Chem
, vol.55
, pp. 1559-1563
-
-
Ausch, C.1
Kim, Y.H.2
Tsuchiya, K.D.3
-
31
-
-
19944432471
-
Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps
-
Petko Z, Ghiassi M, Shuber A, et al., Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 2005; 11: 1203-9. (Pubitemid 40175772)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.3
, pp. 1203-1209
-
-
Petko, Z.1
Ghiassi, M.2
Shuber, A.3
Gorham, J.4
Smalley, W.5
Washington, M.K.6
Schultenover, S.7
Gautam, S.8
Markowitz, S.D.9
Grady, W.M.10
-
32
-
-
0030921194
-
Participation in colorectal cancer screening: A review
-
Vernon SW,. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997; 89: 1406-22. (Pubitemid 27419204)
-
(1997)
Journal of the National Cancer Institute
, vol.89
, Issue.19
, pp. 1406-1422
-
-
Vernon, S.W.1
-
33
-
-
10844281210
-
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population
-
DOI 10.1056/NEJMoa033403
-
Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME,. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-14. (Pubitemid 39665324)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.26
, pp. 2704-2714
-
-
Imperiale, T.F.1
Ransohoff, D.F.2
Itzkowitz, S.H.3
Turnbull, B.A.4
Ross, M.E.5
-
34
-
-
0036132775
-
Stool screening for colorectal cancer: Evolution from occult blood to molecular markers
-
DOI 10.1016/S0009-8981(01)00712-4, PII S0009898101007124
-
Ahlquist DA, Shuber AP,. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin Chim Acta 2002; 315: 157-68. (Pubitemid 33145255)
-
(2002)
Clinica Chimica Acta
, vol.315
, Issue.1-2
, pp. 157-168
-
-
Ahlquist, D.A.1
Shuber, A.P.2
-
35
-
-
0242629046
-
The diagnostic odds ratio: A single indicator of test performance
-
DOI 10.1016/S0895-4356(03)00177-X
-
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM,. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-35. (Pubitemid 37386338)
-
(2003)
Journal of Clinical Epidemiology
, vol.56
, Issue.11
, pp. 1129-1135
-
-
Glas, A.S.1
Lijmer, J.G.2
Prins, M.H.3
Bonsel, G.J.4
Bossuyt, P.M.M.5
-
36
-
-
0031896226
-
Clinical utility of likelihood ratios
-
DOI 10.1016/S0196-0644(98)70352-X
-
Gallagher EJ,. Clinical utility of likelihood ratios. Ann Emerg Med 1998; 31: 391-7. (Pubitemid 28135365)
-
(1998)
Annals of Emergency Medicine
, vol.31
, Issue.3
, pp. 391-397
-
-
Gallagher, E.J.1
|